Viewing data from:

TRAMADOL HYDROCHLORIDE

ANDA

TRAMADOL HYDROCHLORIDE | A076003 | AMNEAL PHARMACEUTICALS OF NEW YORK LLC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.0237

per ea

Lowest NADAC/Unit

$0.0237

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60219234801TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
60219234805TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
60219234807TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
60687079501TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
00904749661TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
65162062710TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
65162062711TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17
65162062750TRAMADOL HCL 50 MG TABLET	$0.0237	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain18 active DMFs21 inactive

15 active API suppliers hold Drug Master Files for this ingredient.

WAVELENGTH ENTERPRISES LTDTRAMADOL HYDROCHLORIDE

DMF 119591996

SUN PHARMACEUTICAL INDUSTRIES LTDTRAMADOL HYDROCHLORIDE USP

DMF 160022002

ZYDUS LIFESCIENCES LTDTRAMADOL HYDROCHLORIDE USP

DMF 170372004

WANBURY LTDTRAMADOL HYDROCHLORIDE

DMF 179702005

JUBILANT BIOSYS LTDTRAMADOL HYDROCHLORIDE USP

DMF 188032005

ARAGEN LIFE SCIENCES LTDTRAMADOL HYDROCHLORIDE

DMF 206322007

CSPC OUYI PHARMACEUTICAL CO LTDTRAMADOL HYDROCHLORIDE

DMF 218052008

RAKS PHARMA PVT LTDTRAMADOL HYDROCHLORIDE USP

DMF 231212009

APITORIA PHARMA PRIVATE LTDTRAMADOL HYDROCHLORIDE USP (NON STERILE DRUG SUBSTANCE)

DMF 242852010

PIRAMAL PHARMA LTDTRAMADOL HYDROCHLORIDE

DMF 249542011

RAKS PHARMA PVT LTDTRAMADOL HYDROCHLORIDE USP API (PROCESS-2)

DMF 271592013

VIRUPAKSHA ORGANICS LTDTRAMADOL HYDROCHLORIDE

DMF 305042016

UNICHEM LABORATORIES LTDTRAMADOL HYDROCHLORIDE USP

DMF 334242019

MACLEODS PHARMACEUTICALS LTDTRAMADOL HYDROCHLORIDE USP

DMF 336212019

SUN PHARMACEUTICAL INDUSTRIES LTDTramadol Hydrochloride USP (Process-II)

DMF 347452020

EMNAR PHARMA PRIVATE LTDTRAMADOL HYDROCHLORIDE USP

DMF 354452021

SUPRIYA LIFESCIENCE LTDTRAMADOL HYDROCHLORIDE USP

DMF 395332024

SUPRIYA LIFESCIENCE LTDTRAMADOL HYDROCHLORIDE USP-(PROCESS II)

DMF 412262025

NORAMCO DELAWARE INCInactiveTRAMADOL HYDROCHLORIDE

DMF 98071992

GRUNENTHAL GMBHInactiveTRAMADOL HYDROCHLORIDE

DMF 98111992

IROTEC LABORATORIESInactiveTRAMADOL HYDROCHLORIDE

DMF 115261995

HELSINN CHEMICALS SAInactiveTRAMADOL HYDROCHLORIDE

DMF 116051995

ZENTIVA ASInactiveTRAMADOL HYDROCHLORIDE

DMF 124041997

WYCKOFF CHEMICAL CO INCInactiveTRAMADOL HYDROCHLORIDE

DMF 128301998

EXCELLA GMBHInactiveTRAMADOL HYDROCHLORIDE

DMF 128691998

SHIJIAZHUANG PHARMACEUTICAL GROUP CO LTDInactiveTRAMADOL HYDROCHLORIDE USP (BULK)

DMF 143331999

EVONIK TECHNOCHEMIE GMBHInactiveTRAMADOL HYDROCHLORIDE

DMF 145411999

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAInactiveTRAMADOL HYDROCHLORIDE

DMF 147612000

DISHMAN PHARMACEUTICALS AND CHEMICALS LTDInactiveTRAMADOL HYDROCHLORIDE

DMF 156302001

PROTO CHEMICALS AGInactiveTRAMADOL HYDROCHLORIDE

DMF 171662004

DAI-ICHI KARKARIA LTDInactiveTRAMADOL HYDROCHLORIDE EP

DMF 174082004

SHIJIAZHUANG PHARMACEUTICAL GROUP HUASHENG PHARMA CO LTDInactiveTRAMADOL HYDROCHLORIDE EP

DMF 185782005

AREVIPHARMA GMBHInactiveTRAMADOL HYDROCHLORIDE

DMF 191172006

TONIRA PHARMA LTDInactiveTRAMADOL HYDROCHLORIDE

DMF 202042007

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDInactiveTramadol Hydrochloride

DMF 212492007

IPCA LABORATORIES LTDInactiveTRAMADOL HYDROCHLORIDE USP

DMF 216792008

KAMUD DRUGS PVT LTDInactiveTRAMADOL HYDROCHLORIDE BP

DMF 219152008

CADILA HEALTHCARE LTDInactiveTRAMADOL HYDROCHLORIDE

DMF 226872009

IPCA LABORATORIES LTDInactiveTRAMADOL HYDROCHLORIDE (YT3 PROCESS)

DMF 247662011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 20, 2002	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 20, 2002

No patent or exclusivity listings for this strength.